Brief Reports
Copyright ©The Author(s) 2005.
World J Gastroenterol. Oct 21, 2005; 11(39): 6165-6169
Published online Oct 21, 2005. doi: 10.3748/wjg.v11.i39.6165
Table 1 Fecal SCFAs in TEN patients and HVO
Before treatment Concentration (SEM)During treatment
After treatment
Concentration (SEM)Difference with pre-treatment
Concentration (SEM)Difference with pre-treatment
Value(95%CI)P1Value95%CI)P1
AcetateTEN69.9 (12.3)97.9 (25.2)28.00.18110.3 (24.1)40.40.02
-6.1 ; 36.214.4 ; 71.4
HVO71.3 (10.3)98.4 (29.8)27.10.79111.5 (17.5)40.20.42
-13.1 ; 35.6-7.0 ; 116.0
PropionateTEN20.9 (3.7)26.2 (3.8)5.30.1826.0 (3.4)5.10.18
-0.2 ; 12.6-3.3 ; 14.3
HVO22.9 (3.0)18.4 (2.4)-4.50.323.0 (2.7)0.10.12
-11.8 ; 4.5-3.1 ; 6.9
ButyrateTEN10.1 (2.9)16.0 (4.4)5.80.00412.9 (2.5)2.70.51
0.1 ; 12.3-3.9 ; 12.3
HVO19.2 (3.9)16.4 (3.3)-2.70.6123.3 (3.1)4.10.12
-9.7 ; 5.6-1.4 ; 16.3